171 related articles for article (PubMed ID: 24700099)
21. Genetic basis of antigenic variation in foot-and-mouth disease serotype A viruses from the Middle East.
Upadhyaya S; Ayelet G; Paul G; King DP; Paton DJ; Mahapatra M
Vaccine; 2014 Jan; 32(5):631-8. PubMed ID: 24035435
[TBL] [Abstract][Full Text] [Related]
22. Murine noroviruses comprising a single genogroup exhibit biological diversity despite limited sequence divergence.
Thackray LB; Wobus CE; Chachu KA; Liu B; Alegre ER; Henderson KS; Kelley ST; Virgin HW
J Virol; 2007 Oct; 81(19):10460-73. PubMed ID: 17652401
[TBL] [Abstract][Full Text] [Related]
23. Expression and antigenicity of virus-like particles of norovirus and their application for detection of noroviruses in stool samples.
Kamata K; Shinozaki K; Okada M; Seto Y; Kobayashi S; Sakae K; Oseto M; Natori K; Shirato-Horikoshi H; Katayama K; Tanaka T; Takeda N; Taniguchi K
J Med Virol; 2005 May; 76(1):129-36. PubMed ID: 15778983
[TBL] [Abstract][Full Text] [Related]
24. Sapporo-like human caliciviruses are genetically and antigenically diverse.
Jiang X; Cubitt WD; Berke T; Zhong W; Dai X; Nakata S; Pickering LK; Matson DO
Arch Virol; 1997; 142(9):1813-27. PubMed ID: 9672639
[TBL] [Abstract][Full Text] [Related]
25. Evidence of combined effect of amino acid substitutions within G-H and B-C loops of VP1 conferring serological heterogeneity in foot-and-mouth disease virus serotype A.
Islam MR; Rahman MS; Amin MA; Alam ASMRU; Siddique MA; Sultana M; Hossain MA
Transbound Emerg Dis; 2021 Mar; 68(2):375-384. PubMed ID: 32543041
[TBL] [Abstract][Full Text] [Related]
26. Genotypes, recombinant forms, and variants of norovirus GII.4 in Gipuzkoa (Basque Country, Spain), 2009-2012.
Arana A; Cilla G; Montes M; Gomariz M; PĂ©rez-Trallero E
PLoS One; 2014; 9(6):e98875. PubMed ID: 24893307
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes.
Godi A; Boampong D; Elegunde B; Panwar K; Fleury M; Li S; Zhao Q; Xia N; Christensen ND; Beddows S
J Virol; 2020 Nov; 94(24):. PubMed ID: 32967963
[TBL] [Abstract][Full Text] [Related]
28. Characterization of norovirus-associated traveler's diarrhea.
Ajami N; Koo H; Darkoh C; Atmar RL; Okhuysen PC; Jiang ZD; Flores J; Dupont HL
Clin Infect Dis; 2010 Jul; 51(2):123-30. PubMed ID: 20540620
[TBL] [Abstract][Full Text] [Related]
29. Genetic and antigenic diversity of human caliciviruses (HuCVs) using RT-PCR and new EIAs.
Jiang X; Matson DO; Cubitt WD; Estes MK
Arch Virol Suppl; 1996; 12():251-62. PubMed ID: 9015122
[TBL] [Abstract][Full Text] [Related]
30. GII.4 Human Norovirus: Surveying the Antigenic Landscape.
Mallory ML; Lindesmith LC; Graham RL; Baric RS
Viruses; 2019 Feb; 11(2):. PubMed ID: 30791623
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the neutralizing epitopes of VP7 of the Gottfried strain of porcine rotavirus.
Kang SY; Benfield DA; Gorziglia M; Saif LJ
J Clin Microbiol; 1993 Sep; 31(9):2291-7. PubMed ID: 7691871
[TBL] [Abstract][Full Text] [Related]
32. Characterization of VP6 genes from rotavirus strains collected in the United States from 1996-2002.
Kerin TK; Kane EM; Glass RI; Gentsch JR
Virus Genes; 2007 Dec; 35(3):489-95. PubMed ID: 17564821
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of porcine noroviruses, molecular characterization of emerging porcine sapoviruses from finisher swine in the United States, and unified classification scheme for sapoviruses.
Scheuer KA; Oka T; Hoet AE; Gebreyes WA; Molla BZ; Saif LJ; Wang Q
J Clin Microbiol; 2013 Jul; 51(7):2344-53. PubMed ID: 23678065
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous Immunization with Multivalent Norovirus VLPs Induces Better Protective Immune Responses to Norovirus Than Sequential Immunization.
Malm M; Vesikari T; Blazevic V
Viruses; 2019 Nov; 11(11):. PubMed ID: 31684058
[TBL] [Abstract][Full Text] [Related]
35. Reverse Genetics Approach for Developing Rotavirus Vaccine Candidates Carrying VP4 and VP7 Genes Cloned from Clinical Isolates of Human Rotavirus.
Kanai Y; Onishi M; Kawagishi T; Pannacha P; Nurdin JA; Nouda R; Yamasaki M; Lusiany T; Khamrin P; Okitsu S; Hayakawa S; Ebina H; Ushijima H; Kobayashi T
J Virol; 2020 Dec; 95(2):. PubMed ID: 33087468
[TBL] [Abstract][Full Text] [Related]
36. Mapping of antigenic sites involved in serotype-cross-reactive neutralization on group A rotavirus outercapsid glycoprotein VP7.
Hoshino Y; Nishikawa K; Benfield DA; Gorziglia M
Virology; 1994 Feb; 199(1):233-7. PubMed ID: 8116249
[TBL] [Abstract][Full Text] [Related]
37. Two-way cross-neutralization mediated by a shared P (VP4) serotype between bovine rotavirus strains with distinct G (VP7) serotypes.
Matsuda Y; Isegawa Y; Woode GN; Zheng S; Kaga E; Nakagomi T; Ueda S; Nakagomi O
J Clin Microbiol; 1993 Feb; 31(2):354-8. PubMed ID: 8381812
[TBL] [Abstract][Full Text] [Related]
38. Norovirus GII.17 Virus-Like Particles Bind to Different Histo-Blood Group Antigens and Cross-React with Genogroup II-Specific Mouse Sera.
Malm M; Tamminen K; Vesikari T; Blazevic V
Viral Immunol; 2018 Dec; 31(10):649-657. PubMed ID: 30431404
[TBL] [Abstract][Full Text] [Related]
39. Immunogenetic mechanisms driving norovirus GII.4 antigenic variation.
Lindesmith LC; Beltramello M; Donaldson EF; Corti D; Swanstrom J; Debbink K; Lanzavecchia A; Baric RS
PLoS Pathog; 2012; 8(5):e1002705. PubMed ID: 22615565
[TBL] [Abstract][Full Text] [Related]
40. Role of histo-blood group antigens in primate enteric calicivirus infections.
Sestak K
World J Virol; 2014 Aug; 3(3):18-21. PubMed ID: 25392814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]